share_log

Possible Bearish Signals With Plexus Insiders Disposing Stock

Possible Bearish Signals With Plexus Insiders Disposing Stock

普雷克薩斯內部人士出售股票可能存在消極信號
Simply Wall St ·  09/26 19:05

The fact that multiple Plexus Corp. (NASDAQ:PLXS) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When analyzing insider transactions, it is usually more valuable to know whether insiders are buying versus knowing if they are selling, as the latter sends an ambiguous message. However, if numerous insiders are selling, shareholders should investigate more.

在過去一年中,多位普雷克薩斯公司(納斯達克:PLXS)的內部人士卸掉了大量股份,這可能會引起投資者的關注。在分析內部交易時,了解內部人士是買入還是賣出通常更有價值,因爲後者傳遞出模棱兩可的信息。然而,如果有多名內部人士在賣出,股東應該進行更深入的調查。

While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.

雖然在長期投資方面內部交易並非最重要的事情,但完全忽略內部交易是愚蠢的。

The Last 12 Months Of Insider Transactions At Plexus

在普雷克薩斯公司最近12個月的內部交易中

Over the last year, we can see that the biggest insider sale was by the Chief Strategy Officer, Steven Frisch, for US$1.7m worth of shares, at about US$130 per share. So it's clear an insider wanted to take some cash off the table, even slightly below the current price of US$132. We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. However, while insider selling is sometimes discouraging, it's only a weak signal. It is worth noting that this sale was only 27% of Steven Frisch's holding.

在過去一年中,我們可以看到首席策略官史蒂文·弗裏施(Steven Frisch)進行了美元170萬的股票交易,每股約130美元。因此,顯然有一位內部人士想要套現,即使價格略低於當前的132美元。如果內部人士一直在拋售,尤其是在低於當前價格時拋售,我們通常認爲這是一個負面信號,因爲這意味着他們認爲更低的價格合理。然而,儘管內部人員的賣出有時令人沮喪,但只是一個微弱的信號。值得注意的是,這次交易僅佔史蒂文·弗裏施持有的27%。

In the last year Plexus insiders didn't buy any company stock. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

在過去一年中,普雷克薩斯的內部人士沒有購買任何公司股票。您可以在下方看到過去12個月內部交易(由公司和個人進行)的視覺描述。如果您想確切了解誰以什麼價格何時賣出,只需點擊下方的圖表!

big
NasdaqGS:PLXS Insider Trading Volume September 26th 2024
納斯達克普雷克薩股票的內部交易量於2024年9月26日

I will like Plexus better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.

如果我看到一些大額內部買入交易,我會更喜歡普雷克薩股票。在等待期間,請查看這份免費的小盤股中被低估且最近有相當大量內部買入交易的名單。

Plexus Insiders Are Selling The Stock

普雷克薩公司內部人士正在拋售該股票

The last three months saw significant insider selling at Plexus. In total, insiders dumped US$4.1m worth of shares in that time, and we didn't record any purchases whatsoever. This may suggest that some insiders think that the shares are not cheap.

過去三個月內,普雷克薩公司有大量內部人士拋售該股票。在那段時間裏,內部人士共拋售價值410萬美元的股份,我們並未記錄到任何購買行爲。這可能表明一些內部人士認爲該股票並不便宜。

Insider Ownership

內部人員持股情況

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. I reckon it's a good sign if insiders own a significant number of shares in the company. Plexus insiders own about US$66m worth of shares. That equates to 1.8% of the company. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

查看一家公司的內部持股總額可以幫助您了解他們是否與普通股東利益一致。 如果內部人士在公司擁有大量股份,我認爲這是一個好跡象。普雷克薩斯內部人士擁有價值約6600萬美元的股份。 這相當於該公司的1.8%。這種水平的內部人員所有權不錯,但還不足以引人注目。 這確實表明了相當程度的一致性。

So What Does This Data Suggest About Plexus Insiders?

那麼這些數據對普雷克薩斯的內部人員意味着什麼?內部人員最近出售了普雷克薩斯的股票,但他們沒有購買任何股票。即使我們看過去一年,也沒有看到任何購買行爲。雖然內部人員擁有股票,但數量不多,而且他們一直在出售。我們不急着購買!除了了解正在進行的內部交易,還有助於識別普雷克薩斯面臨的風險。例如:我們已經發現了3個普雷克薩斯的警示信號,你應該知道。

Insiders haven't bought Plexus stock in the last three months, but there was some selling. And there weren't any purchases to give us comfort, over the last year. While insiders do own shares, they don't own a heap, and they have been selling. We're in no rush to buy! So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. To assist with this, we've discovered 1 warning sign that you should run your eye over to get a better picture of Plexus.

內部人員在過去三個月內沒有購買普雷克薩斯股票,但有一些賣出。而在過去一年內也沒有任何購買使我們放心。雖然內部人員擁有股份,但數量不多,並且他們一直在拋售。我們沒有着急買入!因此,了解內部人員的購買或賣出情況是有幫助的,但了解一家公司面臨的風險也很重要。 爲了幫助您,我們發現了1個警示信號,您應該留意,以更好地了解普雷克薩斯。

But note: Plexus may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

但請注意:普雷克薩斯可能不是最好的股票購買選擇。因此,請查看這份免費列表,其中包含有高roe和低債務的有趣公司。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論